The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.

Tian Yang,Xiaorong Zhong,Jun Wang,Zhongzheng Xiang,Yuanyuan Zeng,Siting Yu,Zelei Dai, Ningyue Xu,Ting Luo,Lei Liu

Cancer medicine（2023）

引用 0|浏览10

暂无评分

摘要

There seemed no survival difference in post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 BC patients with contemporary systemic therapy. In addition, PMRT might be exempted in patients with post-chemotherapy ypT1-2ypN1 BC, while not in patients with de novo pT1-2N1 BC.

查看译文

关键词

breast cancer,de novo pT1-2N1,neoadjuvant chemotherapy,post-chemotherapy ypT1-2ypN1,postmastectomy radiotherapy,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要